Administrative Core Abstract The Administrative Core is designed to facilitate all of the operations of the UNC Carolina CCNE (C-CCNE) to assure that the scientific work can proceed with maximal efficiency. Through this core, we will provide general leadership and administrative support to all of the projects and the cores. The Core will be led by Zishan Haroon, M.D.,Ph.D. in conjunction with the C-CCNE co- PIs, Dr. Leaf Huang and Dr. Joel Tepper. The Administrative core will coordinate efforts with NCI and other members of the Alliance and will be responsible for all reporting to the NCI and organizing the annual NCI site visit. The Advisory Programs will be organized through the core, including the Center Executive Committee, the UNC Advisory Committee, the External Advisory Panel and the patient advocates. The core will be responsible for continuing our strong program of pilot projects as well as the auxiliary projects, and will assure appropriate communication and data sharing, facilitating technology transfer and commercialization. In addition, the Administrative Core will be responsible for providing necessary support services that do not warrant a formal CCNE core. These services include biostatistics and bioinformatics support in design and analysis of laboratory experiments, bioinformatics and data sharing as well as providing veterinary pathology support for analysis of histological samples from all of the projects. The Administrative Core will also organize and facilitate all Educational and Outreach activities. These include the Nanomedicine Certificate Program, investigator exchanges that we will host for visiting scientists, the monthly C-CCNE seminar series, and the annual C-CCNE sponsored nanotechnology symposium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA198999-04
Application #
9546629
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Myung, Ja Hye; Eblan, Michael J; Caster, Joseph M et al. (2018) Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. Clin Cancer Res 24:2539-2547
Liu, Qi; Zhu, Hongda; Tiruthani, Karthik et al. (2018) Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma. ACS Nano 12:1250-1261
Song, Wantong; Shen, Limei; Wang, Ying et al. (2018) Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun 9:2237
Hou, Lin; Liu, Qi; Shen, Limei et al. (2018) Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma. Theranostics 8:3781-3796
Liu, Qi; Zhu, Hongda; Liu, Yun et al. (2018) BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunol Immunother 67:299-310
Mi, Yu; Smith, Christof C; Yang, Feifei et al. (2018) A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy. Adv Mater 30:e1706098
Zhou, Jingying; Liu, Man; Sun, Hanyong et al. (2018) Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Gut 67:931-944
Wan, Xiaomeng; Beaudoin, James J; Vinod, Natasha et al. (2018) Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials 192:1-14
Collier, Michael A; Junkins, Robert D; Gallovic, Matthew D et al. (2018) Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists. Mol Pharm 15:4933-4946
Liu, Lina; Wang, Yuhua; Miao, Lei et al. (2018) Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. Mol Ther 26:45-55

Showing the most recent 10 out of 47 publications